Tempsens Instruments Share Price, IPO GMP, Results, Returns and Should You Buy?

Last updated: 26 October 2026

The Tempsens Instruments share price is around ₹535 on the NSE (latest available quote), about 78% above its IPO price of ₹300 but roughly 16% below its listing-day price of ₹634. The Udaipur-based maker of industrial temperature sensors, heaters and specialised cables listed after a ₹650 crore IPO that was subscribed 184 times and opened with a 111% premium, the biggest listing gain of the year so far. Since then the stock has cooled sharply and tested ₹486 earlier this month. This guide covers the latest NSE snapshot, recent sessions, the IPO and its final GMP, business model, yearly financials, valuation, peers, shareholding, key price levels and a balanced answer to the question most readers ask: should you buy Tempsens Instruments now?

Tempsens Instruments Share Price: Latest Snapshot

Tempsens Instruments Last Trading Sessions

The stock fell below the ₹500 mark for the first time in early October, bounced to the ₹560–590 zone, and has since slipped back towards ₹530. Daily swings of 4–5% are common, which is normal for a newly listed small cap.

Tempsens Instruments IPO: Subscription, GMP and Listing Recap

The IPO is closed, so the grey market premium (GMP) no longer matters for new investors. Here is how it played out.

The GMP climbed steadily through the issue and landed within a few rupees of the actual listing price of ₹634. After listing, the stock gave up part of its gains on the first day, closing at ₹586.65.

Tempsens Instruments Business Overview

Tempsens, founded in 1987, is India’s largest manufacturer of contact and non-contact temperature sensors by revenue, with about 10.5% of the overall sensor market and about 21.3% of non-contact sensors in FY26.

Sensors used in steel plants, furnaces and chemical units wear out and are usually replaced every 12 to 24 months, which gives the company a repeat-revenue base on top of project orders. The company serves more than 3,800 customers.

Tempsens Instruments Yearly Financials (FY24 to FY26)

Profits have grown faster than revenue over two years, but growth slowed noticeably in FY26 and margins slipped slightly as the company spent more on people, research and new business lines. The first results as a listed company, for the half year to September, are due by mid-November under market rules and will show whether growth is picking up again.

Tempsens Instruments Valuation and Key Ratios

Even after the fall from ₹634, the stock trades at roughly double the P/E at which the IPO was priced. A return on equity of 13.5% does not obviously justify 7 to 8 times book value, so the price still assumes that growth will pick up again and margins will stay above 24%.

Tempsens Instruments vs Peers

There is no listed Indian company that matches all three of Tempsens’ businesses, so comparisons are partial.

Tempsens earns clearly higher margins than the closest listed names, which supports a premium valuation. The flip side is that it is much smaller and more dependent on project orders from metal and petrochemical customers.

Tempsens Instruments Shareholding Pattern

The promoters are Virendra Prakash Rathi, Vinay Rathi and Pratap Singh Talesara. Almost all of the ₹555 crore offer for sale (1.85 crore shares, about 22% of the company) came from selling shareholders, so most of the money raised went to them and not to the company. The fresh issue of ₹95 crore is meant for debt repayment, manufacturing expansion and general purposes.

Lock-ins matter here. Half of the anchor shares came out of lock-in in September. The rest, about 32 lakh shares or roughly 4% of the company, become free to sell in late November, which can add selling pressure around that time.

Tempsens Instruments Returns and Price Range

Tempsens Instruments Technicals: Key Price Levels

The stock is too new for 50-day or 200-day moving averages to be meaningful, so the levels below come from actual price action. They are reference points, not forecasts.

A close below ₹486 would put the stock in uncharted territory below its post-listing range, while a recovery above ₹590 would suggest that the post-listing correction is over.

What to Watch Next

• First half-year results as a listed company: revenue growth versus the 17.5% seen in FY26, and whether the EBITDA margin holds near 25%.
• Order book and project timing: two-thirds of revenue comes from projects and OEM orders, so delays in customer capital spending show up quickly.
• Anchor lock-in expiry in late November: a possible source of supply in the market.
• Export growth: overseas sales more than doubled in two years, and the next leg depends on new regions and products.
• Metal and petrochemical cycles: these two industries account for about 41% of revenue.
• Debt repayment and capacity expansion: how quickly the fresh-issue money turns into higher output.

Should You Buy Tempsens Instruments Share Now?

No article can tell you what is right for your portfolio, so here is the evidence on both sides. This is not investment advice.

How different investors may look at it:

The honest summary: Tempsens is a well-run, high-margin niche manufacturer with a leading market position, but the stock is priced for strong growth that FY26 did not quite deliver. The first listed-company results will be the real test. Anyone considering it should decide their time horizon, position size and risk limit first, and speak to a SEBI-registered advisor.

Tempsens Instruments Stock Summary: Where It Stands Today

The stock is near ₹535, about 78% above its ₹300 IPO price, about 16% below its listing-day high of ₹634.85 and about 10% above its all-time low of ₹486. The business is profitable, lightly indebted and market-leading, yet growth is slowing, a large lock-in expiry is approaching and valuation is still rich. Bookmark this page for the latest price and results data.

FAQs on Tempsens Instruments

Disclaimer: This article is for information only and is not investment advice. Stock prices are volatile and past performance does not guarantee future returns. Please consult a SEBI-registered advisor before investing.